(1)
Salazar Gómez, L.; Grisales Negrete, J. P. Molecular and Clinical Evidence of the Cardiovascular Benefit of SGLT2 Inhibitors: State of the Art. Med UPB 2022, 41 (2), 145-156. https://doi.org/10.18566/medupb.v41n2.a07.